About RTI Surgical
RTI Surgical, Inc. is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company's business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties. It processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes, and manufactures metal and synthetic implants for distribution to hospitals and surgeons. The Company distributes its implants and services in approximately 50 states and in over 45 countries across the world.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Appliances & Equipment
- Sub-Industry: Health Care Supplies
- Exchange: NASDAQ
- Symbol: RTIX
- CUSIP: 74975N10
- Previous Close: $3.45
- 50 Day Moving Average: $3.27
- 200 Day Moving Average: $3.15
- 52-Week Range: $2.50 - $4.65
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 22.50
- P/E Growth: 11.00
- Market Cap: $203.55M
- Outstanding Shares: 58,157,000
- Beta: 1.49
- Net Margins: 0.24%
- Return on Equity: 4.60%
- Return on Assets: 2.20%
Companies Related to RTI Surgical:
- Debt-to-Equity Ratio: 0.44%
- Current Ratio: 3.65%
- Quick Ratio: 1.15%
What is RTI Surgical's stock symbol?
RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX."
Where is RTI Surgical's stock going? Where will RTI Surgical's stock price be in 2017?
1 analysts have issued 12-month target prices for RTI Surgical's stock. Their predictions range from $4.00 to $4.00. On average, they expect RTI Surgical's stock price to reach $4.00 in the next year.
When will RTI Surgical announce their earnings?
RTI Surgical is scheduled to release their next quarterly earnings announcement on Thursday, February, 23rd 2017.
Who owns RTI Surgical stock?
RTI Surgical's stock is owned by many different of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (6.58%), State Street Corp (1.71%), Royce & Associates LP (1.34%), Kopp Investment Advisors LLC (1.23%), Renaissance Technologies LLC (1.16%) and First Light Asset Management LLC (0.87%).
Who sold RTI Surgical stock? Who is selling RTI Surgical stock?
RTI Surgical's stock was sold by a variety of institutional investors in the last quarter, including First Light Asset Management LLC, Royce & Associates LP, Kopp Investment Advisors LLC, Gabelli Funds LLC, FMR LLC and Two Sigma Investments LP.
Who bought RTI Surgical stock? Who is buying RTI Surgical stock?
RTI Surgical's stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Continental Advisors LLC, Menta Capital LLC, State Street Corp and Dimensional Fund Advisors LP.
How do I buy RTI Surgical stock?
Shares of RTI Surgical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of RTI Surgical stock cost?
One share of RTI Surgical stock can currently be purchased for approximately $3.60.